Clinical responses with T lymphocytes targeting malignancy-associated κ light chains
Carlos A. Ramos(Methodist Hospital), Gianpietro Dotti(University of North Carolina at Chapel Hill)
Cited by 280
Related Papers
Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15
|Blood|2014|738
Clinical and immunological responses after CD30-specific chimeric antigen receptor–redirected lymphocytes
|Journal of Clinical Investigation|2017|368
GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade
|Molecular Therapy|2016|358
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion
|Nature Reviews Clinical Oncology|2022|324